Abstract:Background Induced pluripotent mesenchymal stem cells (iPMSCs) are novel candidates for drug screening, regenerative medicine, and cell therapy. However, introduction of transcription factor encoding genes for induced pluripotent stem cell (iPSC) generation which could be used to generate mesenchymal stem cells is accompanied by the risk of insertional mutations in the target cell genome. Methods We demonstrate a novel method using an inactivated viral particle to package and deliver four purified recombinant Yamanaka transcription factors (Sox2, Oct4, Klf4, and c-Myc) resulting in reprogramming of human primary fibroblasts. Whole genome bisulfite sequencing was used to analyze genome-wide CpG methylation of human iPMSCs. Western blot, quantitative PCR, immunofluorescence, and in-vitro differentiation were used to assess the pluripotency of iPMSCs. Results The resulting reprogrammed fibroblasts show high-level expression of stem cell markers. The human fibroblast-derived iPMSC genome showed gains in DNA methylation in low to medium methylated regions and concurrent loss of methylation in previously hypermethylated regions. Most of the differentially methylated regions are close to transcription start sites and many of these genes are pluripotent pathway associated. We found that DNA methylation of these genes is regulated by the four iPSC transcription factors, which functions as an epigenetic switch during somatic reprogramming as reported previously. These iPMSCs successfully differentiate into three embryonic germ layer cells, both in vitro and in vivo. Following multipotency induction in our study, the delivered transcription factors were degraded, leading to an improved efficiency of subsequent programmed differentiation. Conclusion Recombinant transcription factor based reprogramming and derivatization of iPMSC offers a novel high-efficiency approach for regenerative medicine from patient-derived cells.

Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1

Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells

Glis1 facilitates induction of pluripotency via an epigenome–metabolome–epigenome signalling cascade

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

Manipulating cell fate through reprogramming: approaches and applications

Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells

High-efficiency Generation of Induced Pluripotent Mesenchymal Stem Cells from Human Dermal Fibroblasts Using Recombinant Proteins

Cellular Reprogramming Using Defined Factors and MicroRNAs

Progress in the Reprogramming of Somatic Cells

Resolution of Reprogramming Transition States by Single Cell RNA-Sequencing

Inducing somatic cells into pluripotent stem cells is an important platform to study the mechanism of early embryonic development

Abnormalities in Human Pluripotent Cells Due to Reprogramming Mechanisms

Single Transcription Factor Reprogramming of Hair Follicle Dermal Papilla Cells to Induced Pluripotent Stem Cells

Epigenetic memory in induced pluripotent stem cells

Generation of germline-competent induced pluripotent stem cells

Direct reprogramming to multipotent trophoblast stem cells, and is pluripotency needed for regenerative medicine either?